Evidence map›Paper›PMID 29263906›Full record

ArticleSignal transduction and targeted therapy

Lyn prevents aberrant inflammatory responses to

Rongpeng Li, Lizhu Fang, Qinqin Pu, Ping Lin, Austin Hoggarth, Huang Huang, Xuefeng Li, Guoping Li, Min Wu

Open access · goldAbstract read
In one paragraph

Article in Signal transduction and targeted therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. AKT Isoforms in Macrophage Activation, Polarization, and Survival.Current topics in microbiology and immunology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in immunology · 2020
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Rongpeng LiDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Lizhu FangDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Qinqin PuDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Ping LinDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Austin HoggarthDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Huang HuangDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Xuefeng LiDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Guoping LiInflammation and Allergic Disease Research Unit, First Affiliated Hospital of Southwest Medical University, Luzhou, China.
Min WuDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
University of North Dakota · USAffiliated Hospital of Southwest Medical University · CNJiangsu Normal University · CNSichuan University · CNState Key Laboratory of Biotherapy

Funding

Lung innate immunity against bacterial infectionR01AI109317 · NIAID · UNIVERSITY OF NORTH DAKOTA · PI WU, MIN · 2014 to 2018
$1.7M
NIAID NIH HHS R01 AI109317
6 · The paper itself

Abstract

The pleiotropic Src kinase Lyn has critical roles in host defense in alveolar macrophages against bacterial infection, but the underlying mechanism for Lyn-mediated inflammatory response remains largely elusive. Using mouse

Identifiers

PMID29263906
PMCPMC5661651
OpenAlexW2564467835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.